Patents Assigned to Panag Pharma Inc.
  • Methods for treatment of interstitial cystitis
    Patent number: 10973777
    Abstract: The present application relates to methods and uses of CB2 target agent local anesthetics such as beta-caryophyllene for treatment of interstitial cystitis in a subject, optionally together with the administration or use of an additional agent for treating interstitial cystitis such as dimethyl sulfoxide (DMSO) or methylsulfonylmethane (MSM).
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: April 13, 2021
    Assignee: Panag Pharma Inc.
    Inventors: Melanie Kelly, Christian Lehmann, Mary Lynch